ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Believers “Flout Fundamental Law Of Physics,” Park Says.

August 1, 2008

‘”2015 Goal” Deleted From NCI Web Site.

December 8, 2006

Full Clearinghouse To Meet; Members Reveal Interests In Evaluations

October 28, 1977

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

Funding Opportunities: NCI Meeting Scheduled For Applicants Of RFA On Pediatric Consortium

February 27, 1998

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985